APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Inhalation Anesthetics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Medical Inhalation Anesthetics Market Outlook and Growth Opportunities 2026

21 December 2025194 pages

Choose your research edition.

Industry ResearchMedical Inhalation Anesthetics Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Inhalation Anesthetics Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Medical Inhalation Anesthetics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Inhalation Anesthetics Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Inhalation Anesthetics Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Medical Inhalation Anesthetics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Medical Inhalation Anesthetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medical Inhalation Anesthetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medical Inhalation Anesthetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Medical Inhalation Anesthetics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Medical Inhalation Anesthetics market include Sandoz International GmbH (Novartis), Novartis AG, Lunan Pharmaceutical Group Co. Ltd., Jiangsu Hengrui Medicine Co. Ltd., Fresenius SE & Co., Baxter International Inc., AbbVie Inc., Troikaa Pharmaceuticals, Ltd and Piramal Enterprises Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Medical Inhalation Anesthetics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medical Inhalation Anesthetics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medical Inhalation Anesthetics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Medical Inhalation Anesthetics market size, projected growth trends, production technologies, key applications, and end-use industries.

Medical Inhalation Anesthetics Segment by Company

Sandoz International GmbH (Novartis)

Novartis AG

Lunan Pharmaceutical Group Co. Ltd.

Jiangsu Hengrui Medicine Co. Ltd.

Fresenius SE & Co.

Baxter International Inc.

AbbVie Inc.

Troikaa Pharmaceuticals, Ltd

Piramal Enterprises Ltd.

Maruishi Pharmaceutical

Hikma Pharmaceuticals PLC

Halocarbon Products Corporation

Abbott Laboratories

Medical Inhalation Anesthetics Segment by Type

Isoflurane

Nitrous Oxide

Sevoflurane

Halothane

Desflurane

Others

Medical Inhalation Anesthetics Segment by Application

Hospitals

Ambulatory Surgical Centres

Others

Medical Inhalation Anesthetics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Medical Inhalation Anesthetics status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Medical Inhalation Anesthetics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Medical Inhalation Anesthetics significant trends, drivers, influence factors in global and regions.

6. To analyze Medical Inhalation Anesthetics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Inhalation Anesthetics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Inhalation Anesthetics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Inhalation Anesthetics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Medical Inhalation Anesthetics market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Inhalation Anesthetics industry.

Chapter 3: Detailed analysis of Medical Inhalation Anesthetics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Medical Inhalation Anesthetics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Medical Inhalation Anesthetics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Medical Inhalation Anesthetics Industry Trends Table 2. Medical Inhalation Anesthetics Industry Drivers Table 3. Medical Inhalation Anesthetics Industry Opportunities and Challenges Table 4. Medical Inhalation Anesthetics Industry Restraints Table 5. Global Medical Inhalation Anesthetics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Medical Inhalation Anesthetics Revenue Share by Company (2021-2026) Table 7. Global Medical Inhalation Anesthetics Sales Volume by Company (k units) & (2021-2026) Table 8. Global Medical Inhalation Anesthetics Sales Volume Share by Company (2021-2026) Table 9. Global Medical Inhalation Anesthetics Average Price (US$/unit) of Company (2021-2026) Table 10. Global Medical Inhalation Anesthetics Company Ranking, (2024-2026) & (USD Million) Table 11. Global Medical Inhalation Anesthetics Key Company Manufacturing Base & Headquarters Table 12. Global Medical Inhalation Anesthetics Company, Product Type & Application Table 13. Global Medical Inhalation Anesthetics Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Medical Inhalation Anesthetics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Isoflurane Table 18. Significant Companies of Nitrous Oxide Table 19. Significant Companies of Sevoflurane Table 20. Significant Companies of Halothane Table 21. Significant Companies of Desflurane Table 22. Significant Companies of Others Table 23. Global Medical Inhalation Anesthetics Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Medical Inhalation Anesthetics Sales Volume by Type (2021-2026) & (k units) Table 25. Global Medical Inhalation Anesthetics Sales Volume by Type (2027-2032) & (k units) Table 26. Global Medical Inhalation Anesthetics Sales Volume Share by Type (2021-2026) Table 27. Global Medical Inhalation Anesthetics Sales Volume Share by Type (2027-2032) Table 28. Global Medical Inhalation Anesthetics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Medical Inhalation Anesthetics Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Medical Inhalation Anesthetics Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Medical Inhalation Anesthetics Sales Value Share by Type (2021-2026) Table 32. Global Medical Inhalation Anesthetics Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Hospitals Table 34. Significant Companies of Ambulatory Surgical Centres Table 35. Significant Companies of Others Table 36. Global Medical Inhalation Anesthetics Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Medical Inhalation Anesthetics Sales Volume by Application (2021-2026) & (k units) Table 38. Global Medical Inhalation Anesthetics Sales Volume by Application (2027-2032) & (k units) Table 39. Global Medical Inhalation Anesthetics Sales Volume Share by Application (2021-2026) Table 40. Global Medical Inhalation Anesthetics Sales Volume Share by Application (2027-2032) Table 41. Global Medical Inhalation Anesthetics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Medical Inhalation Anesthetics Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Medical Inhalation Anesthetics Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Medical Inhalation Anesthetics Sales Value Share by Application (2021-2026) Table 45. Global Medical Inhalation Anesthetics Sales Value Share by Application (2027-2032) Table 46. Global Medical Inhalation Anesthetics Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 47. Global Medical Inhalation Anesthetics Sales by Region (2021-2026) & (k units) Table 48. Global Medical Inhalation Anesthetics Sales Market Share by Region (2021-2026) Table 49. Global Medical Inhalation Anesthetics Sales by Region (2027-2032) & (k units) Table 50. Global Medical Inhalation Anesthetics Sales Market Share by Region (2027-2032) Table 51. Global Medical Inhalation Anesthetics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Medical Inhalation Anesthetics Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Medical Inhalation Anesthetics Sales Value Share by Region (2021-2026) Table 54. Global Medical Inhalation Anesthetics Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Medical Inhalation Anesthetics Sales Value Share by Region (2027-2032) Table 56. Global Medical Inhalation Anesthetics Market Average Price (US$/unit) by Region (2021-2026) Table 57. Global Medical Inhalation Anesthetics Market Average Price (US$/unit) by Region (2027-2032) Table 58. Global Medical Inhalation Anesthetics Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 59. Global Medical Inhalation Anesthetics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Medical Inhalation Anesthetics Sales by Country (2021-2026) & (k units) Table 61. Global Medical Inhalation Anesthetics Sales Market Share by Country (2021-2026) Table 62. Global Medical Inhalation Anesthetics Sales by Country (2027-2032) & (k units) Table 63. Global Medical Inhalation Anesthetics Sales Market Share by Country (2027-2032) Table 64. Global Medical Inhalation Anesthetics Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Medical Inhalation Anesthetics Sales Value Market Share by Country (2021-2026) Table 66. Global Medical Inhalation Anesthetics Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Medical Inhalation Anesthetics Sales Value Market Share by Country (2027-2032) Table 68. Sandoz International GmbH (Novartis) Company Information Table 69. Sandoz International GmbH (Novartis) Business Overview Table 70. Sandoz International GmbH (Novartis) Medical Inhalation Anesthetics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Sandoz International GmbH (Novartis) Medical Inhalation Anesthetics Product Portfolio Table 72. Sandoz International GmbH (Novartis) Recent Development Table 73. Novartis AG Company Information Table 74. Novartis AG Business Overview Table 75. Novartis AG Medical Inhalation Anesthetics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Novartis AG Medical Inhalation Anesthetics Product Portfolio Table 77. Novartis AG Recent Development Table 78. Lunan Pharmaceutical Group Co. Ltd. Company Information Table 79. Lunan Pharmaceutical Group Co. Ltd. Business Overview Table 80. Lunan Pharmaceutical Group Co. Ltd. Medical Inhalation Anesthetics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Lunan Pharmaceutical Group Co. Ltd. Medical Inhalation Anesthetics Product Portfolio Table 82. Lunan Pharmaceutical Group Co. Ltd. Recent Development Table 83. Jiangsu Hengrui Medicine Co. Ltd. Company Information Table 84. Jiangsu Hengrui Medicine Co. Ltd. Business Overview Table 85. Jiangsu Hengrui Medicine Co. Ltd. Medical Inhalation Anesthetics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Jiangsu Hengrui Medicine Co. Ltd. Medical Inhalation Anesthetics Product Portfolio Table 87. Jiangsu Hengrui Medicine Co. Ltd. Recent Development Table 88. Fresenius SE & Co. Company Information Table 89. Fresenius SE & Co. Business Overview Table 90. Fresenius SE & Co. Medical Inhalation Anesthetics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Fresenius SE & Co. Medical Inhalation Anesthetics Product Portfolio Table 92. Fresenius SE & Co. Recent Development Table 93. Baxter International Inc. Company Information Table 94. Baxter International Inc. Business Overview Table 95. Baxter International Inc. Medical Inhalation Anesthetics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Baxter International Inc. Medical Inhalation Anesthetics Product Portfolio Table 97. Baxter International Inc. Recent Development Table 98. AbbVie Inc. Company Information Table 99. AbbVie Inc. Business Overview Table 100. AbbVie Inc. Medical Inhalation Anesthetics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. AbbVie Inc. Medical Inhalation Anesthetics Product Portfolio Table 102. AbbVie Inc. Recent Development Table 103. Troikaa Pharmaceuticals, Ltd Company Information Table 104. Troikaa Pharmaceuticals, Ltd Business Overview Table 105. Troikaa Pharmaceuticals, Ltd Medical Inhalation Anesthetics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Troikaa Pharmaceuticals, Ltd Medical Inhalation Anesthetics Product Portfolio Table 107. Troikaa Pharmaceuticals, Ltd Recent Development Table 108. Piramal Enterprises Ltd. Company Information Table 109. Piramal Enterprises Ltd. Business Overview Table 110. Piramal Enterprises Ltd. Medical Inhalation Anesthetics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Piramal Enterprises Ltd. Medical Inhalation Anesthetics Product Portfolio Table 112. Piramal Enterprises Ltd. Recent Development Table 113. Maruishi Pharmaceutical Company Information Table 114. Maruishi Pharmaceutical Business Overview Table 115. Maruishi Pharmaceutical Medical Inhalation Anesthetics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Maruishi Pharmaceutical Medical Inhalation Anesthetics Product Portfolio Table 117. Maruishi Pharmaceutical Recent Development Table 118. Hikma Pharmaceuticals PLC Company Information Table 119. Hikma Pharmaceuticals PLC Business Overview Table 120. Hikma Pharmaceuticals PLC Medical Inhalation Anesthetics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Hikma Pharmaceuticals PLC Medical Inhalation Anesthetics Product Portfolio Table 122. Hikma Pharmaceuticals PLC Recent Development Table 123. Halocarbon Products Corporation Company Information Table 124. Halocarbon Products Corporation Business Overview Table 125. Halocarbon Products Corporation Medical Inhalation Anesthetics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. Halocarbon Products Corporation Medical Inhalation Anesthetics Product Portfolio Table 127. Halocarbon Products Corporation Recent Development Table 128. Abbott Laboratories Company Information Table 129. Abbott Laboratories Business Overview Table 130. Abbott Laboratories Medical Inhalation Anesthetics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 131. Abbott Laboratories Medical Inhalation Anesthetics Product Portfolio Table 132. Abbott Laboratories Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Medical Inhalation Anesthetics Distributors List Table 136. Medical Inhalation Anesthetics Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Medical Inhalation Anesthetics Product Image Figure 2. Global Medical Inhalation Anesthetics Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Inhalation Anesthetics Sales Value (2021-2032) & (US$ Million) Figure 4. Global Medical Inhalation Anesthetics Sales (2021-2032) & (k units) Figure 5. Global Medical Inhalation Anesthetics Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Medical Inhalation Anesthetics Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Isoflurane Image Figure 10. Nitrous Oxide Image Figure 11. Sevoflurane Image Figure 12. Halothane Image Figure 13. Desflurane Image Figure 14. Others Image Figure 15. Global Medical Inhalation Anesthetics Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Medical Inhalation Anesthetics Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Medical Inhalation Anesthetics Sales Volume Share by Type (2021-2032) Figure 18. Global Medical Inhalation Anesthetics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Medical Inhalation Anesthetics Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Medical Inhalation Anesthetics Sales Value Share by Type (2021-2032) Figure 21. Hospitals Image Figure 22. Ambulatory Surgical Centres Image Figure 23. Others Image Figure 24. Global Medical Inhalation Anesthetics Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Medical Inhalation Anesthetics Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Medical Inhalation Anesthetics Sales Volume Share by Application (2021-2032) Figure 27. Global Medical Inhalation Anesthetics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Medical Inhalation Anesthetics Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Medical Inhalation Anesthetics Sales Value Share by Application (2021-2032) Figure 30. Global Medical Inhalation Anesthetics Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 31. Global Medical Inhalation Anesthetics Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Medical Inhalation Anesthetics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Medical Inhalation Anesthetics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Medical Inhalation Anesthetics Sales Value (2021-2032) & (US$ Million) Figure 35. North America Medical Inhalation Anesthetics Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Medical Inhalation Anesthetics Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Medical Inhalation Anesthetics Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Medical Inhalation Anesthetics Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Medical Inhalation Anesthetics Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Medical Inhalation Anesthetics Sales Value (2021-2032) & (US$ Million) Figure 41. South America Medical Inhalation Anesthetics Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Medical Inhalation Anesthetics Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Medical Inhalation Anesthetics Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Medical Inhalation Anesthetics Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Medical Inhalation Anesthetics Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Isoflurane
  • Nitrous Oxide
  • Sevoflurane
  • Halothane
  • Desflurane
  • Others
Applications
  • Hospitals
  • Ambulatory Surgical Centres
  • Others
Companies covered
  • Sandoz International GmbH (Novartis)
  • Novartis AG
  • Lunan Pharmaceutical Group Co. Ltd.
  • Jiangsu Hengrui Medicine Co. Ltd.
  • Fresenius SE & Co.
  • Baxter International Inc.
  • AbbVie Inc.
  • Troikaa Pharmaceuticals, Ltd
  • Piramal Enterprises Ltd.
  • Maruishi Pharmaceutical
  • Hikma Pharmaceuticals PLC
  • Halocarbon Products Corporation
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Medical Inhalation Anesthetics Sales Value (2021-2032)
  4. 1.2.2 Global Medical Inhalation Anesthetics Sales Volume (2021-2032)
  5. 1.2.3 Global Medical Inhalation Anesthetics Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Medical Inhalation Anesthetics Market Dynamics
  1. 2.1 Medical Inhalation Anesthetics Industry Trends
  2. 2.2 Medical Inhalation Anesthetics Industry Drivers
  3. 2.3 Medical Inhalation Anesthetics Industry Opportunities and Challenges
  4. 2.4 Medical Inhalation Anesthetics Industry Restraints
3 Medical Inhalation Anesthetics Market by Company
  1. 3.1 Global Medical Inhalation Anesthetics Company Revenue Ranking in 2025
  2. 3.2 Global Medical Inhalation Anesthetics Revenue by Company (2021-2026)
  3. 3.3 Global Medical Inhalation Anesthetics Sales Volume by Company (2021-2026)
  4. 3.4 Global Medical Inhalation Anesthetics Average Price by Company (2021-2026)
  5. 3.5 Global Medical Inhalation Anesthetics Company Ranking (2024-2026)
  6. 3.6 Global Medical Inhalation Anesthetics Company Manufacturing Base and Headquarters
  7. 3.7 Global Medical Inhalation Anesthetics Company Product Type and Application
  8. 3.8 Global Medical Inhalation Anesthetics Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Medical Inhalation Anesthetics Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Medical Inhalation Anesthetics Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Medical Inhalation Anesthetics Market by Type
  1. 4.1 Medical Inhalation Anesthetics Type Introduction
  2. 4.1.1 Isoflurane
  3. 4.1.2 Nitrous Oxide
  4. 4.1.3 Sevoflurane
  5. 4.1.4 Halothane
  6. 4.1.5 Desflurane
  7. 4.1.6 Others
  8. 4.2 Global Medical Inhalation Anesthetics Sales Volume by Type
  9. 4.2.1 Global Medical Inhalation Anesthetics Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Medical Inhalation Anesthetics Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Medical Inhalation Anesthetics Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Medical Inhalation Anesthetics Sales Value by Type
  13. 4.3.1 Global Medical Inhalation Anesthetics Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Medical Inhalation Anesthetics Sales Value by Type (2021-2032)
  15. 4.3.3 Global Medical Inhalation Anesthetics Sales Value Share by Type (2021-2032)
5 Medical Inhalation Anesthetics Market by Application
  1. 5.1 Medical Inhalation Anesthetics Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Ambulatory Surgical Centres
  4. 5.1.3 Others
  5. 5.2 Global Medical Inhalation Anesthetics Sales Volume by Application
  6. 5.2.1 Global Medical Inhalation Anesthetics Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Medical Inhalation Anesthetics Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Medical Inhalation Anesthetics Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Medical Inhalation Anesthetics Sales Value by Application
  10. 5.3.1 Global Medical Inhalation Anesthetics Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Medical Inhalation Anesthetics Sales Value by Application (2021-2032)
  12. 5.3.3 Global Medical Inhalation Anesthetics Sales Value Share by Application (2021-2032)
6 Medical Inhalation Anesthetics Regional Sales and Value Analysis
  1. 6.1 Global Medical Inhalation Anesthetics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medical Inhalation Anesthetics Sales by Region (2021-2032)
  3. 6.2.1 Global Medical Inhalation Anesthetics Sales by Region: 2021-2026
  4. 6.2.2 Global Medical Inhalation Anesthetics Sales by Region (2027-2032)
  5. 6.3 Global Medical Inhalation Anesthetics Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Medical Inhalation Anesthetics Sales Value by Region (2021-2032)
  7. 6.4.1 Global Medical Inhalation Anesthetics Sales Value by Region: 2021-2026
  8. 6.4.2 Global Medical Inhalation Anesthetics Sales Value by Region (2027-2032)
  9. 6.5 Global Medical Inhalation Anesthetics Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Medical Inhalation Anesthetics Sales Value (2021-2032)
  12. 6.6.2 North America Medical Inhalation Anesthetics Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Medical Inhalation Anesthetics Sales Value (2021-2032)
  15. 6.7.2 Europe Medical Inhalation Anesthetics Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Medical Inhalation Anesthetics Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Medical Inhalation Anesthetics Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Medical Inhalation Anesthetics Sales Value (2021-2032)
  21. 6.9.2 South America Medical Inhalation Anesthetics Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Medical Inhalation Anesthetics Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Medical Inhalation Anesthetics Sales Value Share by Country, 2025 VS 2032
7 Medical Inhalation Anesthetics Country-level Sales and Value Analysis
  1. 7.1 Global Medical Inhalation Anesthetics Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Medical Inhalation Anesthetics Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Medical Inhalation Anesthetics Sales by Country (2021-2032)
  4. 7.3.1 Global Medical Inhalation Anesthetics Sales by Country (2021-2026)
  5. 7.3.2 Global Medical Inhalation Anesthetics Sales by Country (2027-2032)
  6. 7.4 Global Medical Inhalation Anesthetics Sales Value by Country (2021-2032)
  7. 7.4.1 Global Medical Inhalation Anesthetics Sales Value by Country (2021-2026)
  8. 7.4.2 Global Medical Inhalation Anesthetics Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Medical Inhalation Anesthetics Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Medical Inhalation Anesthetics Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Medical Inhalation Anesthetics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sandoz International GmbH (Novartis)
  2. 8.1.1 Sandoz International GmbH (Novartis) Company Information
  3. 8.1.2 Sandoz International GmbH (Novartis) Business Overview
  4. 8.1.3 Sandoz International GmbH (Novartis) Medical Inhalation Anesthetics Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sandoz International GmbH (Novartis) Medical Inhalation Anesthetics Product Portfolio
  6. 8.1.5 Sandoz International GmbH (Novartis) Recent Developments
  7. 8.2 Novartis AG
  8. 8.2.1 Novartis AG Company Information
  9. 8.2.2 Novartis AG Business Overview
  10. 8.2.3 Novartis AG Medical Inhalation Anesthetics Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Novartis AG Medical Inhalation Anesthetics Product Portfolio
  12. 8.2.5 Novartis AG Recent Developments
  13. 8.3 Lunan Pharmaceutical Group Co. Ltd.
  14. 8.3.1 Lunan Pharmaceutical Group Co. Ltd. Company Information
  15. 8.3.2 Lunan Pharmaceutical Group Co. Ltd. Business Overview
  16. 8.3.3 Lunan Pharmaceutical Group Co. Ltd. Medical Inhalation Anesthetics Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Lunan Pharmaceutical Group Co. Ltd. Medical Inhalation Anesthetics Product Portfolio
  18. 8.3.5 Lunan Pharmaceutical Group Co. Ltd. Recent Developments
  19. 8.4 Jiangsu Hengrui Medicine Co. Ltd.
  20. 8.4.1 Jiangsu Hengrui Medicine Co. Ltd. Company Information
  21. 8.4.2 Jiangsu Hengrui Medicine Co. Ltd. Business Overview
  22. 8.4.3 Jiangsu Hengrui Medicine Co. Ltd. Medical Inhalation Anesthetics Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Jiangsu Hengrui Medicine Co. Ltd. Medical Inhalation Anesthetics Product Portfolio
  24. 8.4.5 Jiangsu Hengrui Medicine Co. Ltd. Recent Developments
  25. 8.5 Fresenius SE & Co.
  26. 8.5.1 Fresenius SE & Co. Company Information
  27. 8.5.2 Fresenius SE & Co. Business Overview
  28. 8.5.3 Fresenius SE & Co. Medical Inhalation Anesthetics Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Fresenius SE & Co. Medical Inhalation Anesthetics Product Portfolio
  30. 8.5.5 Fresenius SE & Co. Recent Developments
  31. 8.6 Baxter International Inc.
  32. 8.6.1 Baxter International Inc. Company Information
  33. 8.6.2 Baxter International Inc. Business Overview
  34. 8.6.3 Baxter International Inc. Medical Inhalation Anesthetics Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Baxter International Inc. Medical Inhalation Anesthetics Product Portfolio
  36. 8.6.5 Baxter International Inc. Recent Developments
  37. 8.7 AbbVie Inc.
  38. 8.7.1 AbbVie Inc. Company Information
  39. 8.7.2 AbbVie Inc. Business Overview
  40. 8.7.3 AbbVie Inc. Medical Inhalation Anesthetics Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 AbbVie Inc. Medical Inhalation Anesthetics Product Portfolio
  42. 8.7.5 AbbVie Inc. Recent Developments
  43. 8.8 Troikaa Pharmaceuticals, Ltd
  44. 8.8.1 Troikaa Pharmaceuticals, Ltd Company Information
  45. 8.8.2 Troikaa Pharmaceuticals, Ltd Business Overview
  46. 8.8.3 Troikaa Pharmaceuticals, Ltd Medical Inhalation Anesthetics Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Troikaa Pharmaceuticals, Ltd Medical Inhalation Anesthetics Product Portfolio
  48. 8.8.5 Troikaa Pharmaceuticals, Ltd Recent Developments
  49. 8.9 Piramal Enterprises Ltd.
  50. 8.9.1 Piramal Enterprises Ltd. Company Information
  51. 8.9.2 Piramal Enterprises Ltd. Business Overview
  52. 8.9.3 Piramal Enterprises Ltd. Medical Inhalation Anesthetics Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Piramal Enterprises Ltd. Medical Inhalation Anesthetics Product Portfolio
  54. 8.9.5 Piramal Enterprises Ltd. Recent Developments
  55. 8.10 Maruishi Pharmaceutical
  56. 8.10.1 Maruishi Pharmaceutical Company Information
  57. 8.10.2 Maruishi Pharmaceutical Business Overview
  58. 8.10.3 Maruishi Pharmaceutical Medical Inhalation Anesthetics Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Maruishi Pharmaceutical Medical Inhalation Anesthetics Product Portfolio
  60. 8.10.5 Maruishi Pharmaceutical Recent Developments
  61. 8.11 Hikma Pharmaceuticals PLC
  62. 8.11.1 Hikma Pharmaceuticals PLC Company Information
  63. 8.11.2 Hikma Pharmaceuticals PLC Business Overview
  64. 8.11.3 Hikma Pharmaceuticals PLC Medical Inhalation Anesthetics Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Hikma Pharmaceuticals PLC Medical Inhalation Anesthetics Product Portfolio
  66. 8.11.5 Hikma Pharmaceuticals PLC Recent Developments
  67. 8.12 Halocarbon Products Corporation
  68. 8.12.1 Halocarbon Products Corporation Company Information
  69. 8.12.2 Halocarbon Products Corporation Business Overview
  70. 8.12.3 Halocarbon Products Corporation Medical Inhalation Anesthetics Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Halocarbon Products Corporation Medical Inhalation Anesthetics Product Portfolio
  72. 8.12.5 Halocarbon Products Corporation Recent Developments
  73. 8.13 Abbott Laboratories
  74. 8.13.1 Abbott Laboratories Company Information
  75. 8.13.2 Abbott Laboratories Business Overview
  76. 8.13.3 Abbott Laboratories Medical Inhalation Anesthetics Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Abbott Laboratories Medical Inhalation Anesthetics Product Portfolio
  78. 8.13.5 Abbott Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Medical Inhalation Anesthetics Value Chain Analysis
  2. 9.1.1 Medical Inhalation Anesthetics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Medical Inhalation Anesthetics Sales Mode & Process
  6. 9.2 Medical Inhalation Anesthetics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Medical Inhalation Anesthetics Distributors
  9. 9.2.3 Medical Inhalation Anesthetics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst